Biocept to Present at Upcoming Investor Conferences
September 04, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Sept. 4, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA)...
Biocept Strengthens Its Circulating Tumor Cell IP Position in Europe
September 03, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Sept. 3, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA)...
Biocept Provides Second Quarter Operational Update
August 14, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Aug. 14, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)...
Biocept Appoints Managed Care Expert to Lead Contract and Reimbursement Strategy
August 06, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)...
Biocept Expands Breast Cancer Offering
June 02, 2014 08:30 ET
|
Biocept, Inc.
Blood-based OncoCEE-BR™ Platform now Includes Estrogen Receptor Testing
SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company...
Biocept Announces National Sales Force
May 19, 2014 07:00 ET
|
Biocept, Inc.
SAN DIEGO, May 19, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and Circulating...
Biocept, Inc. Closes $10 Million Term Loan Facility With Oxford Finance LLC
May 07, 2014 16:15 ET
|
Biocept, Inc.
SAN DIEGO, May 7, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular diagnostics company specializing in oncology biomarker detection and monitoring through circulating tumor cells...
Biocept Launches Clinical Research Services for Biomarker Detection in Circulating Tumor DNA
April 28, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, April 28, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular diagnostics company specializing in oncology biomarker detection and monitoring through circulating tumor cells...
Biocept Appoints Commercialization Leader to Implement Global Diagnostic Sales Program
March 24, 2014 11:04 ET
|
Biocept, Inc.
SAN DIEGO, March 24, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) and...
Biocept, Inc. to Present at the 26th Annual ROTH Conference
March 05, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, March 5, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), an oncology diagnostics company focused on improving individual patient treatment, announced today that the Company's...